Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             51 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 An Exploratory Evaluation Framework for e-Clinical Data Management Performance Lee, HyunJu
 2012
 46 5 p. 555-564
 artikel
2 An Exploratory Evaluation Framework for e-Clinical Data Management Performance Lee, HyunJu
 2012
 46 5 p. 555-564
 artikel
3 An Exploratory Evaluation Framework for e-Clinical Data Management Performance Lee, HyunJu
46 5 p. 555-564
 artikel
4 Concepts for the Risk-Based Regulation of Clinical Research on Medicines and Medical Devices Hartmann, Markus
 2012
 46 5 p. 545-554
 artikel
5 Concepts for the Risk-Based Regulation of Clinical Research on Medicines and Medical Devices Hartmann, Markus
 2012
 46 5 p. 545-554
 artikel
6 Concepts for the Risk-Based Regulation of Clinical Research on Medicines and Medical Devices Hartmann, Markus
46 5 p. 545-554
 artikel
7 Corrigendum: Improvement of the Drug Allergy Alert for Nonprescription NSAIDs 2012
 46 5 p. 627
 artikel
8 Corrigendum: Improvement of the Drug Allergy Alert for Nonprescription NSAIDs 2012
 46 5 p. 627-627
 artikel
9 Corrigendum: Improvement of the Drug Allergy Alert for Nonprescription NSAIDs Soller, R.W.
46 5 p. 627
 artikel
10 Cost-Effective Approach to Managing Laboratory Reference Ranges for Local Laboratories in Clinical Research Tantsyura, Vadim
 2012
 46 5 p. 593-599
 artikel
11 Cost-Effective Approach to Managing Laboratory Reference Ranges for Local Laboratories in Clinical Research Tantsyura, Vadim
 2012
 46 5 p. 593-599
 artikel
12 Cost-Effective Approach to Managing Laboratory Reference Ranges for Local Laboratories in Clinical Research Tantsyura, Vadim
46 5 p. 593-599
 artikel
13 Developing Standardized Data: Connecting the Silos Cooper, Charles K.
 2012
 46 5 p. 521-522
 artikel
14 Developing Standardized Data: Connecting the Silos Cooper, Charles K.
 2012
 46 5 p. 521-522
 artikel
15 Developing Standardized Data: Connecting the Silos Cooper, Charles K.
46 5 p. 521-522
 artikel
16 Drug Shortages After the Eastern Japan Earthquake: Experiences in a Tertiary Referral Center Mori, Jinichi
 2012
 46 5 p. 607-610
 artikel
17 Drug Shortages After the Eastern Japan Earthquake: Experiences in a Tertiary Referral Center Mori, Jinichi
 2012
 46 5 p. 607-610
 artikel
18 Drug Shortages After the Eastern Japan Earthquake: Experiences in a Tertiary Referral Center Mori, Jinichi
46 5 p. 607-610
 artikel
19 Editor’s Commentary: A New Category of Articles— Regulatory Commentaries Turner, J. Rick
 2012
 46 5 p. 517-518
 artikel
20 Editor’s Commentary: A New Category of Articles— Regulatory Commentaries Turner, J. Rick
 2012
 46 5 p. 517-518
 artikel
21 Editor’s Commentary: A New Category of Articles— Regulatory Commentaries Turner, J. Rick
46 5 p. 517-518
 artikel
22 Evaluating the Impact of Patient Recruitment and Retention Practices Lamberti, Mary Jo
 2012
 46 5 p. 573-580
 artikel
23 Evaluating the Impact of Patient Recruitment and Retention Practices Lamberti, Mary Jo
 2012
 46 5 p. 573-580
 artikel
24 Evaluating the Impact of Patient Recruitment and Retention Practices Lamberti, Mary Jo
46 5 p. 573-580
 artikel
25 Indicator-Based Assessment on Antimalarial Drug Availability and Utilization Among Selected Public Health Facilities in Southwest Ethiopia Tessema, Alemayehu Tadesse
 2012
 46 5 p. 587-592
 artikel
26 Indicator-Based Assessment on Antimalarial Drug Availability and Utilization Among Selected Public Health Facilities in Southwest Ethiopia Tessema, Alemayehu Tadesse
 2012
 46 5 p. 587-592
 artikel
27 Indicator-Based Assessment on Antimalarial Drug Availability and Utilization Among Selected Public Health Facilities in Southwest Ethiopia Tessema, Alemayehu Tadesse
46 5 p. 587-592
 artikel
28 Join FDA/PhUSE Working Groups to Help Harness the Power of Computational Science Rosario, Lilliam A.
 2012
 46 5 p. 523-524
 artikel
29 Join FDA/PhUSE Working Groups to Help Harness the Power of Computational Science Rosario, Lilliam A.
 2012
 46 5 p. 523-524
 artikel
30 Join FDA/PhUSE Working Groups to Help Harness the Power of Computational Science Rosario, Lilliam A.
46 5 p. 523-524
 artikel
31 Linguistic Validation of the French Canadian Work Productivity and Activity Impairment Questionnaire–General Health Version Gawlicki, Mary
 2012
 46 5 p. 600-606
 artikel
32 Linguistic Validation of the French Canadian Work Productivity and Activity Impairment Questionnaire–General Health Version Gawlicki, Mary
 2012
 46 5 p. 600-606
 artikel
33 Linguistic Validation of the French Canadian Work Productivity and Activity Impairment Questionnaire–General Health Version Gawlicki, Mary
46 5 p. 600-606
 artikel
34 Mathematical Derivation of Therapeutic Index Based on hERG IC50 Taking Into Account Fraction Unbound in Plasma and Clinical Cmax Fryer, Ryan M.
 2012
 46 5 p. 519-520
 artikel
35 Mathematical Derivation of Therapeutic Index Based on hERG IC50 Taking Into Account Fraction Unbound in Plasma and Clinical Cmax Fryer, Ryan M.
 2012
 46 5 p. 519-520
 artikel
36 Mathematical Derivation of Therapeutic Index Based on hERG IC50 Taking Into Account Fraction Unbound in Plasma and Clinical Cmax Fryer, Ryan M.
46 5 p. 519-520
 artikel
37 Potential Factors Influencing Regional Differences and Similarities in Multiregional Clinical Trials Ohishi, Masahiko
 2012
 46 5 p. 565-572
 artikel
38 Potential Factors Influencing Regional Differences and Similarities in Multiregional Clinical Trials Ohishi, Masahiko
 2012
 46 5 p. 565-572
 artikel
39 Potential Factors Influencing Regional Differences and Similarities in Multiregional Clinical Trials Ohishi, Masahiko
46 5 p. 565-572
 artikel
40 Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients Capaldi, Daniel
 2012
 46 5 p. 611-626
 artikel
41 Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients Capaldi, Daniel
 2012
 46 5 p. 611-626
 artikel
42 Quality Aspects of Oligonucleotide Drug Development: Specifications for Active Pharmaceutical Ingredients Capaldi, Daniel
46 5 p. 611-626
 artikel
43 Quality Standards for Antiretrovirals in Indian Pharmacopoeia Vivekanandan, Kalaiselvan
 2012
 46 5 p. 581-586
 artikel
44 Quality Standards for Antiretrovirals in Indian Pharmacopoeia Vivekanandan, Kalaiselvan
 2012
 46 5 p. 581-586
 artikel
45 Quality Standards for Antiretrovirals in Indian Pharmacopoeia Vivekanandan, Kalaiselvan
46 5 p. 581-586
 artikel
46 Regulation of Herbal Dietary Supplements: Is There a Better Way? Zakaryan, Annet
 2012
 46 5 p. 532-544
 artikel
47 Regulation of Herbal Dietary Supplements: Is There a Better Way? Zakaryan, Annet
 2012
 46 5 p. 532-544
 artikel
48 Regulation of Herbal Dietary Supplements: Is There a Better Way? Zakaryan, Annet
46 5 p. 532-544
 artikel
49 Who Advises the Data Monitoring Committee (DMC)? A Review of Regulatory Guidance for Sponsors on DMCs After 5 Years and Advice for DMC Members Glover, Josephine Mary
 2012
 46 5 p. 525-531
 artikel
50 Who Advises the Data Monitoring Committee (DMC)? A Review of Regulatory Guidance for Sponsors on DMCs After 5 Years and Advice for DMC Members Glover, Josephine Mary
 2012
 46 5 p. 525-531
 artikel
51 Who Advises the Data Monitoring Committee (DMC)? A Review of Regulatory Guidance for Sponsors on DMCs After 5 Years and Advice for DMC Members Glover, Josephine Mary
46 5 p. 525-531
 artikel
                             51 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland